Results 141 to 150 of about 38,945 (161)

[Total and regional fat-to-muscle mass ratio and risk of incident benign ovarian neoplasm]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Li H, Huang T, Wang L.
europepmc   +1 more source

[Effect of Cancer Antigen-125 Elimination Rate Constant K and <i>BRCA</i> Mutation Status on the Prognosis of Interval Debulking Surgery in Advanced High-Grade Serous Ovarian Cancer]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Li Y, Li M, Zhang X, Xu H, Li J, Liu H, Peng C.   +6 more
europepmc   +1 more source

[Exploration and clinical application of the "digital and intelligent surgery" diagnosis and treatment workflow for oral and maxillofacial tumors]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
DU W, Zhang W, Yu Y, Liu S, Su H, Hu L, Tang Z, Wu B, Chen Z, Li J, Wang H, Peng X.   +11 more
europepmc   +1 more source

[Heterogeneity of tumor-associated macrophages and precision targeting strategies in hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Huang K, Zhang GQ.
europepmc   +1 more source

[Research progress in diagnosis and treatment of non-tumorous salivary gland diseases]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Cong X, Su J, Wu L, Ding C, Li W, Yu G.
europepmc   +1 more source

[Research progress on liver transplantation therapy for hepatic metastases in gastroenteropancreatic neuroendocrine tumors]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Yang K, Zhang WQ, Chen CY, Jiang WT.
europepmc   +1 more source

[p53-SOAT1 Axis: A Novel Target for Tumor Lipid Metabolism and Therapy]. [PDF]

Zhongguo Fei Ai Za Zhi
Yu X, Xiao Y, Xu B, Li X, Wang H, Ren D.
europepmc   +1 more source

[Current status and future directions of stability reconstruction following spinal tumor resection]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Zhou J, Dong J.
europepmc   +1 more source

[Role of Receptor Tyrosine Kinase AXL in Cancer Targeted Therapy Drug Resistance]. [PDF]

Zhongguo Fei Ai Za Zhi
Zhan S, Chen P, Lv T, Song Y.
europepmc   +1 more source

[Using activity-based protein profiling method to explore the antitumor targets of spiramycin derivatives]. [PDF]

Se Pu
Yang RY, Feng TZ, Pei SJ, Qi H, Piao HL.
europepmc   +1 more source